$HRTX Income Statement | Understand Stock

$HRTX

$0.30 +$0.00 (0.27%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net product sales
Cost of product sales
Gross profit
Operating expenses:
Research and development
General and administrative
Sales and marketing
Total operating expenses
Loss from operations
Other (expense) income, net:
Interest income
Interest expense
Loss on debt extinguishment
Other income
Total other (expense) income, net
Net loss
Other comprehensive (loss) income:
Unrealized (losses) gains on short-term investments
Comprehensive loss
Basic and diluted net loss per share
Shares used in computing basic and diluted net loss per share
Basic net loss per share
Shares used in computing basic net loss per share
Diluted net loss per share
Shares used in computing diluted net loss per share

Comments